PRA

PRA, RPS merger completed

Wednesday, September 25, 2013 12:23 PM

CRO PRA International has completed its merger with ReSearch Pharmaceutical Services (RPS) and the closing of the acquisition by Kohlberg Kravis Roberts.  

More... »

RPS, PRA to merge under KKR ownership

Wednesday, July 31, 2013 01:51 PM

Global investment firm KKR has signed a definitive agreement to acquire ReSearch Pharmaceutical Services (RPS), a global CRO, from Warburg Pincus.

More... »

Genstar Capital to sell PRA to KKR

Monday, June 24, 2013 03:31 PM

Genstar Capital, a middle market private equity firm focusing on investments in select segments of the life sciences, healthcare, financial services, software and industrial technology industries, has announced a definitive agreement to sell global CRO PRA to funds managed by Kohlberg Kravis Roberts & Co.

More... »

PRA Holdings submits draft registration statement for IPO

Wednesday, May 22, 2013 10:27 AM

PRA Holdings, a global CRO, has submitted a confidential draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission (SEC) for a possible initial public offering of shares of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined.

More... »

PRA opens new facility in Wales, creates 100 graduate-level jobs

Friday, May 17, 2013 02:03 PM

PRA, a global CRO, has officially opened its new facility in Swansea, Wales. The expansion is being supported with $1.9 million business finance from the Welsh government.

More... »

PRA Program to create clinical research jobs for new graduates

Wednesday, April 24, 2013 09:23 AM

PRA, a global CRO, has received a $400,000 grant from the Kansas Bioscience Authority (KBA) to create 80 new jobs this year in Kansas. The graduates will be part of the PRA (Preparing for Research Advancement) Program, an innovative career opportunity for new college graduates interested in clinical research and the CRO industry.

More... »

PRA acquires ClinStar

Monday, March 4, 2013 10:43 AM

Raleigh, N.C.-based CRO PRA has acquired privately held ClinStar, a CRO managing phase I-IV clinical trials in the Russian Federation, Ukraine, Belarus and the Baltic States.

More... »

WuXi PharmaTech, PRA form joint venture for Chinese market

Thursday, December 20, 2012 10:32 AM

CRO WuXi PharmaTech, with operations in China and the U.S., and CRO PRA have signed a joint venture agreement to offer a broad platform of phase I-IV clinical trial services in China, Hong Kong and Macau, including clinical trial monitoring, project management, regulatory strategy and submissions, data management, biostatistics, drug safety reporting and medical monitoring.

More... »

PRA expands operations in China

Wednesday, August 22, 2012 01:10 PM

PRA, a global CRO, has opened a second office in China to accommodate its expansion in China and the Asia Pacific region.

More... »

Prevention trial studies population 100% genetically predisposed to early-onset Alzheimer’s

Monday, August 6, 2012 07:00 AM

For the first time ever, an experimental drug is being tested to determine whether it can prevent Alzheimer’s disease in a population that has a 100% genetic predisposition for early onset of the disease. The study, to start next year, will be one of only a few being conducted to test prevention treatments for a genetically predestined disease.

More... »